NCT05332925 - Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2027

Conditions

Lung CancerNSCLCNSCLC Stage IV

Interventions

DRUG

Standard of care immune checkpoint inhbitors

This is NOT an interventional study.

Trial Locations (2)

RECRUITING

The University of Kansas Cancer Center (KUCC), Fairway

RECRUITING

The University of Kansas Cancer Center, Westwood Campus, Kansas City